A jury in June found that Dr. Adams submitted false claims for chelation therapy reimbursements, according to a news release. Medicare reimbursed Dr. Adams for more than $1.1 million for the therapy, which is designed to remove heavy metals from the body.
However, Dr. Adams falsely claimed his patients had heavy metal poisoning in his submissions to Medicare.
The case first came to light when Dr. Adams faced a civil complaint alleging he submitted the false claims between November 2008 and September 2015.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
